GfK Healthcare Introduces Treatment Tracker

In the US, GfK Healthcare has launched a syndicated research service offering data on physicians' brand preferences, current and anticipated prescribing practices, patient treatment algorithms and other insights across more than 30 diseases.

The new Treatment Tracker allows clients to tailor their reports to focus on the specific data that is most relevant and critical to their particular information needs. Uses include validation of custom marketing research, obtaining product/market overviews, assessment of specific product attributes, educating new people on the product team, and providing input to situational analyses and feed forecasts.

'Treatment Tracker is just one example of how GfK Healthcare is responding to clients' challenges by innovating and evolving research,' explained Chief Marketing Officer Maureen McLaughlin. 'The new services does this by providing the cost-efficiency of high quality, comprehensive syndicated research with the ability to completely tailor the information according to the exact information that meets each client's unique needs.'

Further planned extensions include more frequent data collection and reporting and an expansion into global syndicated studies.

GfK Healthcare provides custom health care marketing research in the US. Last month, the firm launched FlashPoints, a custom quantitative mini-study focused on delivering topline information on physicians' perceptions and behavior.

Web site: www.gfkh.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• GfK Germany
• All news